Inherited conditions characterized by a loss of MYELIN in the central nervous system.
Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.
Conditions characterized by loss or dysfunction of myelin (see MYELIN SHEATH) in the brain, spinal cord, or optic nerves secondary to autoimmune mediated processes. This may take the form of a humoral or cellular immune response directed toward myelin or OLIGODENDROGLIA associated autoantigens.

Genetic localization of an autosomal dominant leukodystrophy mimicking chronic progressive multiple sclerosis to chromosome 5q31. (1/27)

The hereditary leukodystrophies represent a group of neurological disorders, in which complete or partial dysmyelination occurs in either the central nervous system (CNS) and/or the peripheral nervous system. Adult-onset autosomal dominant leukodystrophy (ADLD) is a slowly progressive, neurological disorder characterized by symmetrical widespread myelin loss in the CNS, and the phenotype is similar to that of chronic progressive multiple sclerosis. We report clinical, neuroradiological and neuropathological data from the originally reported ADLD family. Furthermore, we have localized the gene that causes ADLD to a 4 cM region on chromosome 5q31. Linkage analysis of this family yielded a LOD score of 5.72 at theta = 0.0 with the microsatellite marker D5S804. Genetic localization will lead to cloning and characterization of the ADLD gene and may yield new insights into myelin biology and demyelinating diseases.  (+info)

Megalencephalic leukoencephalopathy with subcortical cysts. (2/27)

Megalencephalic leukoencephalopathy with subcortical cysts is a rare disease first described in 1995. It is characterized by macrocephaly and early onset white matter degeneration. We report two siblings who were diagnosed to have this disease. This disease must be included in differential diagnosis of macrocephaly with early onset leukoencephalopathy.  (+info)

Decreased asialotransferrin in cerebrospinal fluid of patients with childhood-onset ataxia and central nervous system hypomyelination/vanishing white matter disease. (3/27)

BACKGROUND: A biomarker for the diagnosis of childhood-onset ataxia and central nervous system hypomyelination (CACH)/vanishing white matter disease (VWM) would have clinical utility and pathophysiologic significance. METHODS: We used 2-dimensional gel electrophoresis/mass spectrometry to compare the cerebrospinal fluid proteome of patients with mutation-confirmed CACH/VWM with that of unaffected controls. We characterized selected spots by in-gel digestion, matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry, and nanospray Fourier transform mass spectrometry. RESULTS: A specific transferrin spot pattern was detected in the CSF samples of the CACH/VWM group (n = 7), distinguishing them from the control group (n = 23) and revealing that patients with CACH/VWM have a deficiency of the asialo form of transferrin usually present in healthy cerebrospinal fluid. The glycopeptide structure, determined from isolated transferrin spots by use of in-gel digestion and extraction, was found to be consistent with earlier reports. CONCLUSIONS: The transferrin isoform abnormality in the cerebrospinal fluid of patients with CACH/VWM appears unique and is a potential clinical diagnostic biomarker. The rapid, efficient diagnosis of this disorder would have a significant impact on clinical studies exploring new strategies for the management and treatment of this disease.  (+info)

Statistical diffusion tensor histology reveals regional dysmyelination effects in the shiverer mouse mutant. (4/27)

Shiverer is an important model of central nervous system dysmyelination characterized by a deletion in the gene encoding myelin basic protein with relevance to human dysmyelinating and demyelinating diseases. Perfusion fixed brains from shiverer mutant (C3Fe.SWV Mbp(shi)/Mbp(shi)n = 6) and background control (C3HeB.FeJ, n = 6) mice were compared using contrast enhanced volumetric diffusion tensor magnetic resonance microscopy with a nominal isotropic spatial resolution of 80 mum. Images were accurately coregistered using non-linear warping allowing voxel-wise statistical parametric mapping of tensor invariant differences between control and shiverer groups. Highly significant differences in the tensor trace and both the axial and radial diffusivity were observed within the major white matter tracts and in the thalamus, midbrain, brainstem and cerebellar white matter, consistent with a high density of myelinated axons within these regions. The fractional anisotropy was found to be much less sensitive than the trace and eigenvalues to dysmyelination and associated microanatomic changes.  (+info)

Oligodendroglial dysplasia in two bullmastiff dogs. (5/27)

Leukodystrophies are inherited neurological disorders involving central nervous system white matter. They are uncommon in animals but a few, breed-specific entities have been described. In 2002, two young-adult, purebred Bullmastiff dogs from central New York State presented to their referring veterinarians displaying moderate to severe ataxia of all limbs, spastic tetraparesis that was worse in the pelvic limbs, and a diffuse, action-related, whole-body tremor. Clinical signs were insidious in onset and slowly progressive. Anatomic diagnoses considered were a C1-C5 lesion or, based on the whole-body tremor, a diffuse central nervous system disorder. No gross lesions were apparent in the brain or spinal cord. Histopathologically, numerous, multifocal, sharply demarcated, small, ovoid to angular areas of myelin pallor (plaques) were present throughout the major white matter tracts of the brainstem and spinal cord. These plaques, which often were traversed by axons, did not stain with luxol fast blue for myelin and were associated with minimal astrocytosis. Ultrastructural findings include occasional hypertrophic glia in white matter, rare unmyelinated segments of axons, and focal proliferation of tubule-containing cytoplasmic glial cell processes (oligodendroglial). The described clinical and morphological findings and age of onset are similar to the well-characterized, presumably hereditary, bovine syndrome known as Charolais ataxia or oligodendroglial dysplasia. This article presents the first description of a leukodystrophy in the Bullmastiff breed and the first report of oligodendroglial dysplasia in animals other than Charolais cattle.  (+info)

The ether lipid-deficient mouse: tracking down plasmalogen functions. (6/27)

Chemical and physico-chemical properties as well as physiological functions of major mammalian ether-linked glycerolipids, including plasmalogens were reviewed. Their chemical structures were described and their effect on membrane fluidity and membrane fusion discussed. The recent generation of mouse models with ether lipid deficiency offered the possibility to study ether lipid and particularly plasmalogen functions in vivo. Ether lipid-deficient mice revealed severe phenotypic alterations, including arrest of spermatogenesis, development of cataract and defects in central nervous system myelination. In several cell culture systems lack of plasmalogens impaired intracellular cholesterol distribution affecting plasma membrane functions and structural changes of ER and Golgi cisternae. Based on these phenotypic anomalies that were accurately described conclusions were drawn on putative functions of plasmalogens. These functions were related to cell-cell or cell-extracellular matrix interactions, formation of lipid raft microdomains and intracellular cholesterol homeostasis. There are several human disorders, such as Zellweger syndrome, rhizomelic chondrodysplasia punctata, Alzheimer's disease, Down syndrome, and Niemann-Pick type C disease that are distinguished by altered tissue plasmalogen concentrations. The role plasmalogens might play in the pathology of these disorders is discussed.  (+info)

Hypomyelination and congenital cataract: neuroimaging features of a novel inherited white matter disorder. (7/27)

BACKGROUND AND PURPOSE: Hypomyelination and congenital cataract (HCC) is an autosomal recessive white matter disease caused by deficiency of hyccin, a membrane protein implicated in both central and peripheral myelination. We aimed to describe the neuroimaging features of this novel entity. MATERIALS AND METHODS: A systematic analysis of patients with unclassified leukoencephalopathies admitted to our institutions revealed 10 children with congenital cataract, slowly progressive neurologic impairment, and diffuse white matter abnormalities on neuroimaging. Psychomotor developmental delay was evident after the first year of life. Peripheral neuropathy was demonstrated by neurophysiologic studies in 9 children. The available neuroimaging studies were retrospectively reviewed. RESULTS: In all patients, neuroimaging revealed diffuse involvement of the supratentorial white matter associated with preservation of both cortical and deep gray matter structures. Supratentorial white matter hypomyelination was detected in all patients; 7 patients also had evidence of variably extensive areas of increased white matter water content. Deep cerebellar white matter hypomyelination was found in 6 patients. Older patients had evidence of white matter bulk loss and gliosis. Proton MR spectroscopy showed variable findings, depending on the stage of the disease. Sural nerve biopsy revealed hypomyelinated nerve fibers. Mutations in the DRCTNNB1A gene on chromosome 7p15.3, causing complete or severe deficiency of hyccin, were demonstrated in all patients. CONCLUSIONS: HCC is characterized by a combined pattern of primary myelin deficiency and secondary neurodegenerative changes. In the proper clinical setting, recognition of suggestive neuroimaging findings should prompt appropriate genetic investigations.  (+info)

MR imaging characteristics and neuropathology of the spinal cord in adult-onset autosomal dominant leukodystrophy with autonomic symptoms. (8/27)

 (+info)

Hereditary Central Nervous System (CNS) Demyelinating Diseases are a group of rare, inherited genetic disorders that affect the nervous system. These diseases are characterized by damage to the myelin sheath, which is the protective covering surrounding nerve fibers in the CNS (brain and spinal cord). The damage to the myelin sheath results in disrupted communication between the brain and other parts of the body, leading to various neurological symptoms.

Examples of Hereditary CNS Demyelinating Diseases include:

1. Leukodystrophies - A group of genetic disorders that affect the white matter (myelin) in the brain. Examples include Pelizaeus-Merzbacher disease, Krabbe disease, and Metachromatic leukodystrophy.
2. Hereditary Spastic Paraplegias (HSPs) - A group of inherited disorders that cause progressive stiffness and weakness in the legs due to damage to the nerve fibers in the spinal cord. Some forms of HSP can also involve CNS demyelination.
3. Neurodegenerative disorders with brain iron accumulation (NBIA) - A group of rare genetic disorders characterized by abnormal accumulation of iron in the brain, which can lead to damage to the myelin sheath and other structures in the brain. Examples include Pantothenate kinase-associated neurodegeneration (PKAN) and Neuroferritinopathy.
4. Cerebrotendinous xanthomatosis - A rare inherited disorder of bile acid metabolism that can lead to progressive neurological symptoms, including demyelination in the brain and spinal cord.

These disorders are typically diagnosed through genetic testing, medical history, physical examination, and imaging studies such as MRI. Treatment is focused on managing symptoms and slowing disease progression, and may include medications, physical therapy, and other supportive care measures.

Demyelinating diseases are a group of disorders that are characterized by damage to the myelin sheath, which is the protective covering surrounding nerve fibers in the brain, optic nerves, and spinal cord. Myelin is essential for the rapid transmission of nerve impulses, and its damage results in disrupted communication between the brain and other parts of the body.

The most common demyelinating disease is multiple sclerosis (MS), where the immune system mistakenly attacks the myelin sheath. Other demyelinating diseases include:

1. Acute Disseminated Encephalomyelitis (ADEM): An autoimmune disorder that typically follows a viral infection or vaccination, causing widespread inflammation and demyelination in the brain and spinal cord.
2. Neuromyelitis Optica (NMO) or Devic's Disease: A rare autoimmune disorder that primarily affects the optic nerves and spinal cord, leading to severe vision loss and motor disability.
3. Transverse Myelitis: Inflammation of the spinal cord causing damage to both sides of one level (segment) of the spinal cord, resulting in various neurological symptoms such as muscle weakness, numbness, or pain, depending on which part of the spinal cord is affected.
4. Guillain-Barré Syndrome: An autoimmune disorder that causes rapid-onset muscle weakness, often beginning in the legs and spreading to the upper body, including the face and breathing muscles. It occurs when the immune system attacks the peripheral nerves' myelin sheath.
5. Central Pontine Myelinolysis (CPM): A rare neurological disorder caused by rapid shifts in sodium levels in the blood, leading to damage to the myelin sheath in a specific area of the brainstem called the pons.

These diseases can result in various symptoms, such as muscle weakness, numbness, vision loss, difficulty with balance and coordination, and cognitive impairment, depending on the location and extent of the demyelination. Treatment typically focuses on managing symptoms, modifying the immune system's response, and promoting nerve regeneration and remyelination when possible.

The Central Nervous System (CNS) is the part of the nervous system that consists of the brain and spinal cord. It is called the "central" system because it receives information from, and sends information to, the rest of the body through peripheral nerves, which make up the Peripheral Nervous System (PNS).

The CNS is responsible for processing sensory information, controlling motor functions, and regulating various autonomic processes like heart rate, respiration, and digestion. The brain, as the command center of the CNS, interprets sensory stimuli, formulates thoughts, and initiates actions. The spinal cord serves as a conduit for nerve impulses traveling to and from the brain and the rest of the body.

The CNS is protected by several structures, including the skull (which houses the brain) and the vertebral column (which surrounds and protects the spinal cord). Despite these protective measures, the CNS remains vulnerable to injury and disease, which can have severe consequences due to its crucial role in controlling essential bodily functions.

Demyelinating autoimmune diseases of the central nervous system (CNS) are a group of disorders characterized by inflammation and damage to the myelin sheath, which is the protective covering that surrounds nerve fibers in the brain and spinal cord. This damage can result in various neurological symptoms, including muscle weakness, sensory loss, vision problems, and cognitive impairment.

The most common demyelinating autoimmune disease of the CNS is multiple sclerosis (MS), which affects approximately 2.3 million people worldwide. Other examples include neuromyelitis optica spectrum disorder (NMOSD), acute disseminated encephalomyelitis (ADEM), and transverse myelitis.

These conditions are thought to arise when the immune system mistakenly attacks the myelin sheath, leading to inflammation, damage, and scarring (sclerosis) in the CNS. The exact cause of this autoimmune response is not fully understood, but it is believed to involve a complex interplay between genetic, environmental, and immunological factors.

Treatment for demyelinating autoimmune diseases of the CNS typically involves a combination of medications to manage symptoms, reduce inflammation, and modify the course of the disease. These may include corticosteroids, immunosuppressive drugs, and disease-modifying therapies (DMTs) that target specific components of the immune system.

A hereditary CNS demyelinating disease is a demyelinating central nervous system disease that is primarily due to an inherited ... "Hereditary Central Nervous System Demyelinating Diseases - Genetics Home Reference". Archived from the original on 2010-04-08. ... Demyelinating diseases of CNS, All stub articles, Nervous system disease stubs). ... Alexander disease Canavan disease Krabbe disease leukoencephalopathy with vanishing white matter megalencephalic ...
... hereditary central nervous system demyelinating diseases MeSH C10.574.500.495 - hereditary motor and sensory neuropathies MeSH ... central nervous system MeSH C10.228.140.300.850.125 - aids arteritis, central nervous system MeSH C10.228.140.300.850.250 - ... central nervous system MeSH C10.500.190.600 - central nervous system venous angioma MeSH C10.500.190.800 - sinus pericranii ... central nervous system MeSH C10.114.875.350 - lupus vasculitis, central nervous system MeSH C10.114.875.700 - temporal ...
Bargiela D, Chinnery PF (September 2019). "Mitochondria in neuroinflammation - Multiple sclerosis (MS), leber hereditary optic ... "Inflammatory demyelinating diseases of the central nervous system". Neuropathology. Handbook of Clinical Neurology. Vol. 145. ... Autoimmune diseases, Central nervous system disorders, Idiopathic diseases). ... See Anti-neurofascin demyelinating diseases Some anti-neurofascin demyelinating diseases were previously considered a subtype ...
... hereditary central nervous system demyelinating diseases MeSH C16.320.400.400 - hereditary motor and sensory neuropathies MeSH ... central nervous system cyst MeSH C16.131.666.142.100 - arachnoid cyst MeSH C16.131.666.190 - central nervous system vascular ... central nervous system MeSH C16.131.666.190.600 - central nervous system venous angioma MeSH C16.131.666.190.800 - sinus ... cholesterol ester storage disease MeSH C16.320.565.580.554 - lysosomal storage diseases, nervous system MeSH C16.320.565.580. ...
Demyelinating diseases can be divided in those affecting the central nervous system (CNS) and those affecting the peripheral ... demyelinating polyneuropathy Anti-MAG peripheral neuropathy Charcot-Marie-Tooth disease and its counterpart Hereditary ... MS is an inflammatory demyelinating disease of the central nervous system (CNS) that develops in genetically susceptible ... Fernández O, Fernández VE, Guerrero M (2015). "Demyelinating diseases of the central nervous system". Medicine. 11 (77): 4601- ...
... central nervous system MeSH C20.111.258.962.400 - lupus vasculitis, central nervous system MeSH C20.111.258.962.800 - temporal ... Still's disease, adult-onset MeSH C20.111.258.250 - demyelinating autoimmune diseases, cns MeSH C20.111.258.250.175 - diffuse ... hereditary sensory and autonomic neuropathies MeSH C20.111.258.750.600.250 - dysautonomia, familial MeSH C20.111.258.750.800 - ... central nervous system MeSH C20.111.736.700 - pemphigus, benign familial MeSH C20.188.413.480 - hydrops fetalis MeSH C20.188. ...
... sclerosis 341 Other demyelinating diseases of central nervous system 341.0 Neuromyelitis optica 341.1 Schilder's disease 341.8 ... Hereditary peripheral neuropathy 356.1 Peroneal muscular atrophy 356.2 Hereditary sensory neuropathy 356.3 Refsum's disease ... This is a shortened version of the sixth chapter of the ICD-9: Diseases of the Nervous System and Sense Organs. It covers ICD ... Infectious and parasitic diseases. However, as it results in a disorder of the nervous system, it is also listed in this ...
CAA is present in all regions of the central nervous system. Other symptoms include intention tremor, neurofibrillary tangles, ... Toriello, Helga V.; Smith, Shelley D. (2013-08-08). Hereditary Hearing Loss and Its Syndromes. OUP USA. p. 489. ISBN 978-0-19- ... Differential diagnosis includes Begger syndrome and Refsum disease. Most people with this condition die when they reach their ... and the presence of exceedingly thin and nearly totally demyelinated cranial nerves. FDD is an autosomal dominant disorder ...
Central Nervous System Megalencephaly The M in MLC stands for "megalencephaly", the enlargement of the brain Ataxia Slow, ... is a form of hereditary CNS demyelinating disease. It belongs to a group of disorders called leukodystrophies. It is ... MRI testing is used to study and diagnose patients with this disease. A study conducted on four patients with this disease ... Demyelinating diseases of CNS, Genetic disorders with known gene but no known gene function, All stub articles, Genetic ...
They accumulate in the peripheral nervous system where HSAN manifest, but not in the central nervous system in mice bearing a ... is a group of autosomal dominant inherited neurological diseases that affect the peripheral nervous system particularly on the ... In addition, motor conduction is slow, possibly implying a demyelinating process. Advances in molecular genetics have enabled ... Dnmt1 is highly expressed in post-mitotic neurons in the adult central nervous system, with peak expression during the S-phase ...
... non-LHON-affected retinal ganglion cells produce less of the potent superoxide radical than other normal central nervous system ... The Rescue of Hereditary Optic Disease Outpatient Study (RHODOS) evaluated the effects of idebenone in 85 patients with LHON ... of LHON plus have been compared to multiple sclerosis because of the lack of muscular control and the presence of demyelinating ... experiments may in part explain the death of LHON-affected retinal ganglion cells in preference to other central nervous system ...
The level of PMP22 expression is relatively low in the central nervous system of adults. Like other membrane proteins, newly ... Dejerine-Sottas disease, and Hereditary Neuropathy with Liability to Pressure Palsy (HNPP). Too much PMP22 (e.g. caused by gene ... Brennan KM, Bai Y, Shy ME (2015). "Demyelinating CMT--what's known, what's new and what's in store?". Neuroscience Letters. 596 ... Patel PI, Lupski JR (Apr 1994). "Charcot-Marie-Tooth disease: a new paradigm for the mechanism of inherited disease". Trends in ...
Multiple sclerosis (MS) is a chronic debilitating demyelinating disease of the central nervous system, caused by an autoimmune ... can also cause hereditary PD or increase PD risk. While PD is the second most common neurodegenerative disorder, problems with ... Parkinson's disease, Alzheimer's disease, Huntington's disease, multiple system atrophy, and prion diseases. Neurodegeneration ... June 2020). "The CLN3 Disease Staging System: A new tool for clinical research in Batten disease". Neurology. 94 (23): e2436- ...
Wood-allum, Clare A.; Shaw, Pamela J. (2014). "Thyroid disease and the nervous system". Neurologic Aspects of Systemic Disease ... Genetic diseases: Friedreich's ataxia, Fabry disease, Charcot-Marie-Tooth disease, hereditary neuropathy with liability to ... After ruling out a lesion in the central nervous system as a cause, diagnosis may be made on the basis of symptoms, laboratory ... In demyelinating polyneuropathies, the myelin sheath around axons is damaged, which affects the ability of the axons to conduct ...
"Pathological findings in central nervous system demyelination associated with infliximab". Multiple Sclerosis Journal. 26 (9): ... The involvement of anti-neurofascin 155 antibodies in central and peripheral demyelinating diseases, Neuroimmunol ... August 1995). "Leber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy". J. Neurol. ... After that, a whole spectrum of diseases named NMO spectrum diseases (NMOSD) or anti-AQP4 diseases has been accepted. Later, it ...
... is a part of the capillary system that prevents the entry of T cells into the central nervous system. It may become permeable ... MS is not considered a hereditary disease, but several genetic variations have been shown to increase the risk. Some of these ... but it is normally something similar to anti-MOG demyelinating diseases. A third kind of auto-antibodies is accepted. They are ... MS is the most common autoimmune disorder of the central nervous system. The latest estimation of the total number of people ...
Medical Center where he demonstrated that HTLV-I was associated with a demyelinating disease of the central nervous system. ... Most notably he led the research that identified the genetic bases for several craniofacial abnormalities and hereditary ... Ehrlich's research on the etiology of chronic middle-ear disease (otitis media) in the early 1990s in which he exploited the ... Ehrlich's research works have led to the mapping and cloning of multiple human disease genes (alleles) as we well as the ...
Motor neuron diseases, Systemic atrophies primarily affecting the central nervous system, Rare diseases). ... Imaging studies to rule out structural or demyelinating lesions may be done as well. Hoffman's sign and Babinski reflex may be ... PLS is not considered hereditary when onset is in adulthood; however, juvenile primary lateral sclerosis (JPLS) has been linked ... PLS belongs to a group of disorders known as motor neuron diseases. Motor neuron diseases develop when the nerve cells that ...
... (CIDP) is an acquired autoimmune disease of the peripheral nervous system ... multifocal acquired demyelinating sensory and motor neuropathy). A variant with CNS involvement named combined central and ... hereditary, vasculitic) cannot be excluded, or when profound axonal involvement is observed on EMG. Ultrasound of the ... Autoimmune disease Neurological disorder "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Information Page". ninds.nih ...
... the cells responsible for myelination in the central nervous system. The myelinoid protocol pioneered in 2018, and subsequently ... an auto-immune demyelinating disease affecting the CNS.Clemastine and ketoconazole are promyelinating drugs that function as ... hereditary genetic diseases and cancer". Cell & Bioscience. 12 (1): 39. doi:10.1186/s13578-022-00775-w. PMC 8973959. Kim, ... "Novel in vitro Experimental Approaches to Study Myelination and Remyelination in the Central Nervous System". Frontiers in ...
... , absent in the central nervous system, is a major component of the myelin sheath in peripheral nerves. ... "Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32 ... "De novo mutation of the myelin P0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III)". Nature ... The myelin sheath is a multi-layered membrane, unique to the nervous system, that functions as an insulator to greatly increase ...
There also exist at least two types (2E and PCWH) that can result in central nervous system (CNS) symptoms such as ... and Hirschsprung's disease, as seen in type 4). When this happens, it is called peripheral demyelinating neuropathy-central ... also confirmed a hereditary pattern to dystopia canthorum. This later led to the synonym Van der Hoeve-Halbertsma-Waardenburg- ... which myelinate the peripheral nervous system to allow sufficient conductivity, odontoblasts, which produce dentin deep in the ...
Cennamo-Gangemi syndrome Central core disease Central diabetes insipidus Central nervous system protozoal infections Central ... dysfunction syndrome Chronic fatigue syndrome Chronic granulomatous disease Chronic hiccup Chronic inflammatory demyelinating ... photocontact Continuous muscle fiber activity hereditary Continuous spike-wave during slow sleep syndrome Contractural ... Marie-Tooth disease type 1A Charcot-Marie-Tooth disease type 1B Charcot-Marie-Tooth disease type 1C Charcot-Marie-Tooth disease ...
In the central nervous system they can detect damage to the spinothalamic tract, lateral brain stem, and fibers carrying pain ... VEP may be abnormal in optic neuritis, optic neuropathy, demyelinating disease, multiple sclerosis, Friedreich's ataxia, ... Furthermore, SEPs could be abnormal in different pathologies such as multiple sclerosis (MS), hereditary spinocerebellar ... Sensory evoked potentials (SEP) are recorded from the central nervous system following stimulation of sense organs, for example ...
... and several diseases of the central nervous system (see Clinical Significance). Nerve excitability examination complements ... is the most common form of hereditary neuropathy and can be further subdivided into two types: Type 1: demyelinating, and Type ... Machado-Joseph disease (MJD) is a triplet repeat disease characterized by cerebellar ataxia, pyramidal signs, ophthalmoplegia, ... Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immunological demyelinating polyneuropathy. As a result of ...
... indications for production in the central nervous system". Scandinavian Journal of Clinical and Laboratory Investigation. 39 (7 ... The role of cystatin C in multiple sclerosis and other demyelinating diseases (characterized by a loss of the myelin nerve ... Levy E, Lopez-Otin C, Ghiso J, Geltner D, Frangione B (May 1989). "Stroke in Icelandic patients with hereditary amyloid ... several types of cardiovascular disease (including myocardial infarction, stroke, heart failure, peripheral arterial disease ...
Neurodegenerative diseases of the central nervous system can affect the brain and/or spinal cord. This article will cover the ... The main group of sensory neuron diseases are hereditary sensory and autonomic neuropathies (HSAN) such as HSAN I, HSAN II, and ... is a demyelinating neurodegenerative disease that does not have a confirmed cause, but is widely considered to be an autoimmune ... complex disorders linked by the degeneration of neurons in either the peripheral nervous system or the central nervous system. ...
Hereditary Central Nervous System Demyelinating Diseases / genetics * Hereditary Central Nervous System Demyelinating Diseases ... Hereditary Central Nervous System Demyelinating Diseases / diagnostic imaging * Hereditary Central Nervous System Demyelinating ... Objective: Hypomyelinating disorders are a group of clinically and genetically heterogeneous diseases characterized by ... Nine different hypomyelinating disorders were identified in 119 patients: Pelizaeus-Merzbacher disease (94, 79%), Pelizaeus- ...
A hereditary CNS demyelinating disease is a demyelinating central nervous system disease that is primarily due to an inherited ... "Hereditary Central Nervous System Demyelinating Diseases - Genetics Home Reference". Archived from the original on 2010-04-08. ... Demyelinating diseases of CNS, All stub articles, Nervous system disease stubs). ... Alexander disease Canavan disease Krabbe disease leukoencephalopathy with vanishing white matter megalencephalic ...
Hereditary Central Nervous System Demyelinating Diseases [C10.228.518.625]. *Pelizaeus-Merzbacher Disease [C10.228.518.625.775] ... Hereditary Central Nervous System Demyelinating Diseases [C10.228.140.695.625]. *Pelizaeus-Merzbacher Disease [C10.228.140.695. ... Hereditary Central Nervous System Demyelinating Diseases [C16.320.565.189.362]. *Pelizaeus-Merzbacher Disease [C16.320.565.189. ... Hereditary Central Nervous System Demyelinating Diseases [C18.452.132.100.362]. *Pelizaeus-Merzbacher Disease [C18.452.132.100. ...
Hereditary Central Nervous System Demyelinating Diseases. C16.320.400.393 C16.320.400.367. Herpes Simplex Virus Protein Vmw65 ... Central Nervous System Venous Angioma C14.240.850.875.124. Central Venous Pressure G9.330.553.400.114.732.336 G9.330.553.660. ... Lupus Vasculitis, Central Nervous System. C10.114.875.350 C10.114.875.850. C10.228.140.300.850.250 C10.228.140.300.850.750. ... Hemangioma, Cavernous, Central Nervous System. C14.907.934.385.500 C14.240.850.875.249. C14.907.454.385.500. Hematocrit G9.188. ...
Hereditary Central Nervous System Demyelinating Diseases. C16.320.400.393 C16.320.400.367. Herpes Simplex Virus Protein Vmw65 ... Central Nervous System Venous Angioma C14.240.850.875.124. Central Venous Pressure G9.330.553.400.114.732.336 G9.330.553.660. ... Lupus Vasculitis, Central Nervous System. C10.114.875.350 C10.114.875.850. C10.228.140.300.850.250 C10.228.140.300.850.750. ... Hemangioma, Cavernous, Central Nervous System. C14.907.934.385.500 C14.240.850.875.249. C14.907.454.385.500. Hematocrit G9.188. ...
Hereditary Central Nervous System Demyelinating Diseases. C16.320.400.393 C16.320.400.367. Herpes Simplex Virus Protein Vmw65 ... Central Nervous System Venous Angioma C14.240.850.875.124. Central Venous Pressure G9.330.553.400.114.732.336 G9.330.553.660. ... Lupus Vasculitis, Central Nervous System. C10.114.875.350 C10.114.875.850. C10.228.140.300.850.250 C10.228.140.300.850.750. ... Hemangioma, Cavernous, Central Nervous System. C14.907.934.385.500 C14.240.850.875.249. C14.907.454.385.500. Hematocrit G9.188. ...
Hereditary Central Nervous System Demyelinating Diseases. C16.320.400.393 C16.320.400.367. Herpes Simplex Virus Protein Vmw65 ... Central Nervous System Venous Angioma C14.240.850.875.124. Central Venous Pressure G9.330.553.400.114.732.336 G9.330.553.660. ... Lupus Vasculitis, Central Nervous System. C10.114.875.350 C10.114.875.850. C10.228.140.300.850.250 C10.228.140.300.850.750. ... Hemangioma, Cavernous, Central Nervous System. C14.907.934.385.500 C14.240.850.875.249. C14.907.454.385.500. Hematocrit G9.188. ...
Hereditary Central Nervous System Demyelinating Diseases. C16.320.400.393 C16.320.400.367. Herpes Simplex Virus Protein Vmw65 ... Central Nervous System Venous Angioma C14.240.850.875.124. Central Venous Pressure G9.330.553.400.114.732.336 G9.330.553.660. ... Lupus Vasculitis, Central Nervous System. C10.114.875.350 C10.114.875.850. C10.228.140.300.850.250 C10.228.140.300.850.750. ... Hemangioma, Cavernous, Central Nervous System. C14.907.934.385.500 C14.240.850.875.249. C14.907.454.385.500. Hematocrit G9.188. ...
Hereditary Central Nervous System Demyelinating Diseases. C16.320.400.393 C16.320.400.367. Herpes Simplex Virus Protein Vmw65 ... Central Nervous System Venous Angioma C14.240.850.875.124. Central Venous Pressure G9.330.553.400.114.732.336 G9.330.553.660. ... Lupus Vasculitis, Central Nervous System. C10.114.875.350 C10.114.875.850. C10.228.140.300.850.250 C10.228.140.300.850.750. ... Hemangioma, Cavernous, Central Nervous System. C14.907.934.385.500 C14.240.850.875.249. C14.907.454.385.500. Hematocrit G9.188. ...
Hereditary Central Nervous System Demyelinating Diseases. C16.320.400.393 C16.320.400.367. Herpes Simplex Virus Protein Vmw65 ... Central Nervous System Venous Angioma C14.240.850.875.124. Central Venous Pressure G9.330.553.400.114.732.336 G9.330.553.660. ... Lupus Vasculitis, Central Nervous System. C10.114.875.350 C10.114.875.850. C10.228.140.300.850.250 C10.228.140.300.850.750. ... Hemangioma, Cavernous, Central Nervous System. C14.907.934.385.500 C14.240.850.875.249. C14.907.454.385.500. Hematocrit G9.188. ...
Hereditary Central Nervous System Demyelinating Diseases. C16.320.400.393 C16.320.400.367. Herpes Simplex Virus Protein Vmw65 ... Central Nervous System Venous Angioma C14.240.850.875.124. Central Venous Pressure G9.330.553.400.114.732.336 G9.330.553.660. ... Lupus Vasculitis, Central Nervous System. C10.114.875.350 C10.114.875.850. C10.228.140.300.850.250 C10.228.140.300.850.750. ... Hemangioma, Cavernous, Central Nervous System. C14.907.934.385.500 C14.240.850.875.249. C14.907.454.385.500. Hematocrit G9.188. ...
Hereditary Central Nervous System Demyelinating Diseases. C16.320.400.393 C16.320.400.367. Herpes Simplex Virus Protein Vmw65 ... Central Nervous System Venous Angioma C14.240.850.875.124. Central Venous Pressure G9.330.553.400.114.732.336 G9.330.553.660. ... Lupus Vasculitis, Central Nervous System. C10.114.875.350 C10.114.875.850. C10.228.140.300.850.250 C10.228.140.300.850.750. ... Hemangioma, Cavernous, Central Nervous System. C14.907.934.385.500 C14.240.850.875.249. C14.907.454.385.500. Hematocrit G9.188. ...
Hereditary Central Nervous System Demyelinating Diseases. C16.320.400.393 C16.320.400.367. Herpes Simplex Virus Protein Vmw65 ... Central Nervous System Venous Angioma C14.240.850.875.124. Central Venous Pressure G9.330.553.400.114.732.336 G9.330.553.660. ... Lupus Vasculitis, Central Nervous System. C10.114.875.350 C10.114.875.850. C10.228.140.300.850.250 C10.228.140.300.850.750. ... Hemangioma, Cavernous, Central Nervous System. C14.907.934.385.500 C14.240.850.875.249. C14.907.454.385.500. Hematocrit G9.188. ...
Hereditary Central Nervous System Demyelinating Diseases. C16.320.400.393 C16.320.400.367. Herpes Simplex Virus Protein Vmw65 ... Central Nervous System Venous Angioma C14.240.850.875.124. Central Venous Pressure G9.330.553.400.114.732.336 G9.330.553.660. ... Lupus Vasculitis, Central Nervous System. C10.114.875.350 C10.114.875.850. C10.228.140.300.850.250 C10.228.140.300.850.750. ... Hemangioma, Cavernous, Central Nervous System. C14.907.934.385.500 C14.240.850.875.249. C14.907.454.385.500. Hematocrit G9.188. ...
An astrogliopathy and a form of Alexander disease (AxD) characterized by ataxia, bulbar symptoms, spastic paraparesis, palatal ... Brain Diseases, Metabolic, Inborn*Hereditary Central Nervous System Demyelinating Diseases*Alexander disease*Alexander disease ... Congenital, Hereditary, and Neonatal Diseases and Abnormalities*Inborn genetic diseases*Inborn errors of metabolism* ... Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 ...
Hereditary Central Nervous System Demyelinating Diseases [C10.228.140.163.100.362]. *Canavan Disease [C10.228.140.163.100.362. ... Brain Diseases, Metabolic, Inborn [C16.320.565.189]. *Hereditary Central Nervous System Demyelinating Diseases [C16.320.565.189 ... Brain Diseases, Metabolic, Inborn [C18.452.132.100]. *Hereditary Central Nervous System Demyelinating Diseases [C18.452.132.100 ... Brain Diseases, Metabolic, Inborn [C18.452.648.189]. *Hereditary Central Nervous System Demyelinating Diseases [C18.452.648.189 ...
Of special interest is differential diagnosis of optic neuropathy in demyelinating diseases of the central nervous system, ... hereditary optic neuropathies and ischemic optic neuropathy. The article presents a summary of scientific and practical results ... Visual System Involvement in Glial Fibrillary Acidic Protein Astrocytopathy: Two Case Reports and a Systematic Literature ... In patients with follow-up information, a relapsing disease course was more frequently observed in those with vs without visual ...
Demyelinating Diseases [C10.314] * Demyelinating Autoimmune Diseases, CNS [C10.314.350] * Hereditary Central Nervous System ... Nervous System Diseases [C10] * Central Nervous System Diseases [C10.228] * Brain Diseases [C10.228.140] * Headache Disorders [ ... Nervous System Diseases [C10] * Cranial Nerve Diseases [C10.292] * Abducens Nerve Diseases [C10.292.150] ... Nervous System Diseases [C10] * Cranial Nerve Diseases [C10.292] * Ocular Motility Disorders [C10.292.562] * Ophthalmoplegia [ ...
CMTX1 has both demyelinating and axonal features. Central nervous system involvement may occur.. Defects in GJB1 may contribute ... CMTX1 is a form of Charcot-Marie-Tooth disease, the most common inherited disorder of the peripheral nervous system. Charcot- ... or hereditary motor and sensory neuropathy III (HMSN3). DSS is a severe degenerating neuropathy of the demyelinating Charcot- ... Involvement in disease. Defects in GJB1 are the cause of Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800]; also ...
Hartnup Disease. *Hepatolenticular Degeneration. *Hereditary Central Nervous System Demyelinating Diseases. *Homocystinuria. * ... "Hartnup Disease" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical Subject ... This graph shows the total number of publications written about "Hartnup Disease" by people in this website by year, and ... Below are the most recent publications written about "Hartnup Disease" by people in Profiles. ...
Demyelinating Autoimmune Diseases, CNS. *Hereditary Central Nervous System Demyelinating Diseases. *Leukoencephalopathy, ... Childhood Ataxia with Central Nervous System Hypomyelinization*Childhood Ataxia with Central Nervous System Hypomyelinization ... Any of various diseases affecting the white matter of the central nervous system. ... Expanding the horizon of research into the pathogenesis of the white matter diseases: Proceedings of the 2021 Annual Workshop ...
Hereditary Central Nervous System Demyelinating Diseases. *Hereditary Sensory and Autonomic Neuropathies. *Hereditary Sensory ... Heredodegenerative Disorders, Nervous System [C10.574.500]. *Pantothenate Kinase-Associated Neurodegeneration [C10.574.500.700] ... Heredodegenerative Disorders, Nervous System [C16.320.400]. *Pantothenate Kinase-Associated Neurodegeneration [C16.320.400.650] ... Nervous System Diseases [C10]. *Central Nervous System Diseases [C10.228]. *Brain Diseases [C10.228.140] ...
Hereditary Central Nervous System Demyelinating Diseases [C16.320.400.367] * Hereditary Sensory and Motor Neuropathy [C16.320. ... Hereditary Central Nervous System Demyelinating Diseases [C10.574.500.490] * Hereditary Sensory and Autonomic Neuropathies [ ... Nervous System Diseases [C10] * Neuromuscular Diseases [C10.668] * Peripheral Nervous System Diseases [C10.668.829] * ... Nervous System Diseases [C10] * Neurodegenerative Diseases [C10.574] * Heredodegenerative Disorders, Nervous System [C10.574. ...
Hereditary Central Nervous System Demyelinating Diseases [C10.228.140.163.100.362] * Homocystinuria [C10.228.140.163.100.365] ... Nervous System Diseases [C10] * Central Nervous System Diseases [C10.228] * Brain Diseases [C10.228.140] * Brain Diseases, ... Infantile Refsum Disease Infantile Refsums Disease Refsum Disease, Infantile Form Refsums Disease, Infantile Previous ... Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] * Genetic Diseases, Inborn [C16.320] * Metabolism, Inborn ...
Central Nervous System Demyelinating Diseases, Hereditary -- See Hereditary Central Nervous System Demyelinating Diseases ... Central Nervous System Demyelinating Hereditary Diseases -- See Hereditary Central Nervous System Demyelinating Diseases ... Central nervous system -- Atlases. 4 Central nervous system -- Atlases.y : The human central nervous system : a synopsis and ... Central nervous system -- Diseases. 115 Central nervous system -- Diseases -- Age factors. : Aging and recovery of function in ...
Demyelinating Autoimmune Diseases, CNS. *Hereditary Central Nervous System Demyelinating Diseases. *Leukoencephalopathy, ... "Myelinolysis, Central Pontine" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH ( ... A demyelinating condition affecting the PONS and characterized clinically by an acute progressive QUADRIPLEGIA; DYSARTHRIA; ... This graph shows the total number of publications written about "Myelinolysis, Central Pontine" by people in this website by ...
Hereditary Central Nervous System Demyelinating Diseases. *Leukoencephalopathies. *Magnetic Resonance Imaging. *Mutation. * ... Central Nervous System Fungal Infections. *Central Nervous System Parasitic Infections. *Central Nervous System Viral Diseases ... Central Nervous System Infections [C10.228.228]. *Central Nervous System Viral Diseases [C10.228.228.210] ... Nervous System Diseases [C10]. *Central Nervous System Diseases [C10.228]. *Brain Diseases [C10.228.140] ...
HEREDITARY CENTRAL NERVOUS SYSTEM DEMYELINATING DISEASES ENFERMEDADES DESMIELINIZANTES DEL SISTEMA NERVIOSO CENTRAL ... VIROSES DO SISTEMA NERVOSO CENTRAL CENTRAL NERVOUS SYSTEM VIRAL DISEASES ENFERMEDADES VIRALES DEL SISTEMA NERVIOSO CENTRAL ... CENTRAL NERVOUS SYSTEM HELMINTHIASIS HELMINTIASIS DEL SISTEMA NERVIOSO CENTRAL HEMANGIOMA CAVERNOSO DO SISTEMA NERVOSO CENTRAL ... VASCULITIS POR LUPUS DEL SISTEMA NERVIOSO CENTRAL VASCULITE DO SISTEMA NERVOSO CENTRAL VASCULITIS, CENTRAL NERVOUS SYSTEM ...
Hartnup Disease. *Hepatolenticular Degeneration. *Hereditary Central Nervous System Demyelinating Diseases. *Homocystinuria. * ... Lysosomal Storage Diseases, Nervous System*Lysosomal Storage Diseases, Nervous System. *Lysosomal Enzyme Disorders, Nervous ... Lysosomal Storage Diseases, Nervous System [C10.228.140.163.100.435]. *Congenital, Hereditary, and Neonatal Diseases and ... Nervous System" by people in this website by year, and whether "Lysosomal Storage Diseases, Nervous System" was a major or ...
Central nervous system demyelinating disorder. Chronic obstructive pulmonary disease. Hepatic impairment. Hepatitis B. ... Chronic obstructive pulmonary disease. Hepatic impairment. Hepatitis B. Hereditary fructose intolerance. History of cancer. ... Predisposition to demyelinating disorder. Predisposition to infection. Surgery. Tobacco smoking. Central nervous system ... with pre-existing or recent onset of demyelinating disease or in those at an increased risk of developing demyelinating disease ...
  • hereditary neuropathies, acquired neuropathies. (unicampania.it)
  • Inherited peripheral neuropathies (IPNs) are a heterogeneous group of hereditary motor and sensory neuropathies (HMSN), hereditary motor neuropathies, and hereditary sensory neuropathies. (annaly-nevrologii.com)
  • That complicates the differential diagnosis of hereditary neuropathies. (annaly-nevrologii.com)
  • CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis. (annaly-nevrologii.com)
  • The PMP22 gene is located on chromosome 17p11.2 and mutations as well as alterations in the gene dosage are causative for a group of hereditary neuropathies affecting approximately 1 in 2500 humans 2 , 3 . (biorxiv.org)
  • CMT (Charcot-Marie-Tooth) disease is a heterogeneous group of inherited peripheral neuropathies in which the neuropathy is the sole or primary component of the disorder. (cmt.org.uk)
  • CMTX and CMT type 4 (CMT4 - usually autosomal recessive) are also demyelinating neuropathies. (cmt.org.uk)
  • There are different types of motor neuropathies, including multifocal motor neuropathy (MMN), which is a rare disease that affects the body's motor nerves . (gshs.org)
  • Hypomyelinating disorders are a group of clinically and genetically heterogeneous diseases characterized by neurological deterioration with hypomyelination visible on brain MRI scans. (nih.gov)
  • A group of enzymatic disorders affecting the nervous system and to a variable degree the skeletal system, lymphoreticular system, and other organs. (childrensmercy.org)
  • [9] A LHON -associated MS [10] has also been reported, and in addition there have been inconclusive reports of TNF-α blockers inducing demyelinating disorders. (mdwiki.org)
  • These conditions can appear as Neuromyelitis optica (NMO), and its associated "spectrum of disorders" (NMOSD), currently considered a common syndrome for several separated diseases [16] but with some still idiopathic subtypes. (mdwiki.org)
  • Hypomyelinating leukodystrophies are a group of neurodevelopmental disorders in which a permanent deficiency in [5 genes] the amount of myelin occurs in the central nervous system, either due to its abnormal formation or to altered oligodendrocyte differentiation or migration. (healthincode.com)
  • On the other hand, unlike demyelinating disorders where the T1-weighed sequence signal is hypointense, changes in this sequence can be isointense or slightly hypo- or hyperintense. (healthincode.com)
  • Among the most frequent disorders is Pelizaeus-Merzbacher disease (PMD) , caused by pathogenic variants in the PLP1 gene, as well as a series of diseases with similar clinical and radiologic features, known as PMD-like diseases (PMDL), caused by defects in GJC2, AIMP1, or HSPD . (healthincode.com)
  • Hereditary spastic paraplegias (HSPs) encompass a group of neurodegenerative disorders with lower limb spasticity due to degeneration of the corticospinal tract as most prominent sign. (biomedcentral.com)
  • 128 patients (58 women, 70 men) from 109 families were recruited by specialised HSP outpatient clinics in Bochum, Kiel, and Tübingen, Germany, in the context of the German Network of Hereditary Movement Disorders (GeNeMove). (biomedcentral.com)
  • Disorders such as Charcot-Marie-Tooth disease are hereditary types of neuropathy that run in families. (mayoclinic.org)
  • An expanding number of degenerative disorders are associated with mutations in the genes encoding MFN2 and OPA1, including Charcot-Marie-Tooth disease type 2A and autosomal dominant optic atrophy. (centrodinoferrari.com)
  • While these disorders can still be considered rare, defective mitochondrial dynamics seem to play a significant role in the molecular and cellular pathogenesis of more common neurodegenerative diseases, for example, Alzheimer's and Parkinson's diseases. (centrodinoferrari.com)
  • The Department of Neurology at Healing Hospital deals with managing and treating disorders related to the nervous system of the body. (healinghospital.co.in)
  • The neurologist treats disorders that affect the brain, spinal cord, and nerves, such as: Cerebrovascular disease, such as stroke. (healinghospital.co.in)
  • Neurology is a medical speciality dealing with disorders of the nervous system. (wikidoc.org)
  • Neurological disorders are disorders that affect the central nervous system ( brain and spinal cord ), the peripheral nervous system , or the autonomic nervous system . (wikidoc.org)
  • Information about Pelizaeus-Merzbacher disease is also available from the National Institutes of Health (NIH) at http://www.ninds.nih.gov/disorders/pelizaeus_merzbacher/pelizaeus_merzbacher.htm. (medscape.com)
  • In the late 1960s, neurophysiologic testing allowed the classification of CMT into 2 groups, one with slow nerve conduction velocities and histologic features of a hypertrophic demyelinating neuropathy (hereditary motor and sensory neuropathy type 1 or CMT1) and another with relatively normal velocities and axonal and neuronal degeneration (hereditary motor and sensory neuropathy type 2 or CMT2). (medscape.com)
  • Stimulation produces an action potential that travels up the axon toward the spinal cord and past the cell bodies of the sensory axons of the large-fiber sensory system in the dorsal root ganglia to the ipsilateral posterior columns of the spinal cord. (medscape.com)
  • Comprehensive electrophysiological testing disclosed a more widespread affection of long fibre tracts involving peripheral nerves and the sensory system in 40%, respectively. (biomedcentral.com)
  • Whereas HSP is primarily considered as an upper motoneuron disorder, our data suggest a more widespread affection of motor and sensory tracts in the central and peripheral nervous system as a common finding in HSP. (biomedcentral.com)
  • To analyse the spread of long fibre tract affection in HSP and to explore potential effects of different pathomechanisms in distinct genotypes we studied motor and sensory involvement of the central and peripheral nervous system by clinical and electrophysiological means in a representative cohort of HSP patients. (biomedcentral.com)
  • The peripheral nerves also send sensory information to the central nervous system through sensory nerves. (mayoclinic.org)
  • In contrast to the motor system, the cell bodies of the afferent sensory fibers lie outside the spinal cord, in dorsal root ganglia. (msdmanuals.com)
  • CMT type 2 (CMT2 - also known as hereditary motor and sensory neuropathy type II (HMSN-II)) is primarily an axonal disorder, not a demyelinating disorder. (cmt.org.uk)
  • Neurological manifestations are caused by disorder in the central and the peripheral nervous system. (amedi.sk)
  • Epilepsy is a central nervous system (neurological) disorder in which brain activity becomes abnormal, causing seizures or periods of unusual behavior, sensations and sometimes loss of awareness Anyone can develop epilepsy. (brainandnervecenter.com)
  • It is a rare chronic demyelinating disorder that affects the optic nerve and spinal cord. (brainandnervecenter.com)
  • Optic neuromyelitis, also known as Devic's disorder or neuromyelitis optica, is a central nervous system disease that primarily affects the eye and spinal cord. (brainandnervecenter.com)
  • Multiple sclerosis (MS) is an autoimmune demyelinating disorder of the central nervous system. (clinlabint.com)
  • Peripheral neuropathy is a general term for any disorder of the peripheral nervous system. (nih.gov)
  • These include metabolic conditions such as kidney disease or liver disease, and an underactive thyroid, also known as hypothyroidism. (mayoclinic.org)
  • Inflammatory demyelinating diseases (IDDs), sometimes called Idiopathic (IIDDs) due to the unknown etiology of some of them, are a heterogenous group of demyelinating diseases - conditions that cause damage to myelin , the protective sheath of nerve fibers - that occur against the background of an acute or chronic inflammatory process. (mdwiki.org)
  • Multiple sclerosis ( MS ) is a disease that causes demyelination (disruption of the myelin that insulates and protects nerve cells) of spinal nerve and brain cells. (medicinenet.com)
  • Multiple sclerosis is a disease that involves an immune-mediated process that results in an abnormal response in the body's immune system that damages central nervous system (CNS) tissues in which the immune system attacks myelin, the substance that surrounds and insulates nerve fibers causing demyelination that leads to nerve damage. (medicinenet.com)
  • Duplication of the gene encoding the myelin protein PMP22 causes the hereditary neuropathy Charcot-Marie-Tooth disease 1A (CMT1A), characterized by hypomyelination of medium to large caliber peripheral axons. (biorxiv.org)
  • Conversely, haplo-insufficiency of PMP22 leads to focal myelin overgrowth in hereditary neuropathy with liability to pressure palsies (HNPP). (biorxiv.org)
  • A hallmark of the HNPP disease is the formation of tomacula, extensive formation of myelin sheaths at cytoplasmic areas, such as paranodes and Schmidt-Lanterman incisures leading to deformed and constricted axons and subsequently demyelination 7 - 9 . (biorxiv.org)
  • A demyelinating disease is an ailment that causes damage to the protective coating (myelin sheath) that covers nerve fibres in the brain, optic nerves, and spinal cord. (a2zfitnessmart.com)
  • The most frequent demyelinating disease of the central nervous system is multiple sclerosis (MS). As per research , under MS, the immune system damages the myelin sheath or the cells that make and sustain this sheath. (a2zfitnessmart.com)
  • Autosomal recessive forms can be also divided into demyelinating (CMT4 or AR-CMT1) and axonal forms (AR-CMT2). (medscape.com)
  • Traditionally, CMT pathophysiology has been categorized into 2 processes: a predominant demyelinating process resulting in low conduction velocities (CMT1) and a predominant axonal process resulting in low potential amplitudes (CMT2). (medscape.com)
  • However, even for CMT1 a heated debate has focused on the relative contribution of axonal versus demyelinative damage to the disease manifestations and progression. (medscape.com)
  • Whereas all patients showed clinical signs of spastic paraparesis, MEPs were normal in 27% of patients and revealed a broad spectrum with axonal or demyelinating features in the others. (biomedcentral.com)
  • Conditions linked to CMT with comparable symptoms include: HNPP - Hereditary Neuropathy with Liability to Pressure Palsies, GAN - Giant Axonal Neuropathy. (cmt.org.uk)
  • The main clinical features used to classify peripheral neuropathy are distribution, type (mainly demyelinating versus mainly axonal), duration, and course. (nih.gov)
  • GDAP1 mutations are frequent among Brazilian patients with autosomal recessive axonal Charcot-Marie-Tooth disease. (cdc.gov)
  • However, disease course is varied, reflecting both genotypic and phenotypic heterogeneity. (cmt.org.uk)
  • This is in contrast to autoimmune demyelinating conditions, such as multiple sclerosis, or conditions such as central pontine myelinolysis that are associated with acute acquired insult. (wikipedia.org)
  • They are sometimes considered different diseases from Multiple Sclerosis, [4] [5] but considered by others to form a spectrum differing only in terms of chronicity, severity, and clinical course. (mdwiki.org)
  • Multiple sclerosis for some people is a syndrome more than a single disease. (mdwiki.org)
  • Some anti- neurofascin demyelinating diseases were previously considered a subtype of Multiple Sclerosis but now they are considered a separate entity, as it happened before to anti-MOG and anti-AQP4 cases. (mdwiki.org)
  • Optic neuritis (ON) is a demyelinating inflammation of the optic nerve that often occurs in association with multiple sclerosis (MS) and, much less commonly, neuromyelitis optica (NMO). (medscape.com)
  • Because the exact antigen or target of the immune-mediated attack is not known, many experts prefer to label multiple sclerosis as 'immune-mediated instead of an autoimmune disease. (medicinenet.com)
  • Multiple sclerosis is a disease that causes demyelination of the brain and spinal cord nerve cells. (medicinenet.com)
  • Our world-class experts are committed to your neurological care, whether you've got Alzheimer's disease, multiple sclerosis, epilepsy, ALS or any other neurological disease. (healinghospital.co.in)
  • Demyelinating diseases of the central nervous system, such as multiple sclerosis. (healinghospital.co.in)
  • We performed a systematic review of the literature according to PRISMA guidelines, including all patients with this disease and available clinical data, focusing on visual involvement. (bvsalud.org)
  • An early onset form of phytanic acid storage disease with clinical and biochemical signs different from those of REFSUM DISEASE . (nih.gov)
  • Therefore, one given pathogenic underlying condition can yield several clinical diseases, and one disease can be produced by several pathogenic conditions. (mdwiki.org)
  • A distinct clinical entity from other inflammatory demyelinating diseases. (mdwiki.org)
  • The epilepsy, parkinsonism, progressive ataxia, spastic paraparesis, and demyelinating polyneuropathy occur in the clinical picture of a neurological nature. (amedi.sk)
  • For CMTX1 there is usually subclinical central nervous system involvement (eg, mild clinical signs, MRI cerebral white matter abnormalities, and EEG abnormalities). (cmt.org.uk)
  • This information helps the neurologist determine if the problem exists in the nervous system and the clinical localization. (wikidoc.org)
  • Although Pelizaeus-Merzbacher disease and X-linked spastic paraplegia type 2 are nosologically distinguished, they are at opposite ends of a clinical spectrum of X-linked diseases caused by mutations of the same gene, the proteolipid protein 1 ( PLP1 ) gene, and result in defective central nervous system (CNS) myelination (see the image below). (medscape.com)
  • Severe clinical syndromes (sometimes referred to as the connatal forms of Pelizaeus-Merzbacher disease) are typically caused by missense and other small mutations that affect critical positions in PLP1 , whereas the milder spastic paraplegia syndrome is caused by mutations that presumably affect less critical regions of the protein. (medscape.com)
  • Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE). (nih.gov)
  • Psoriasis is a chronic inflammatory autoimmune skin disease, characterized by the formation of erythematous scaly plaques on the skin and joints. (clinlabint.com)
  • Behçet's disease (BD) is a chronic inflammatory and multisystemic autoimmune disease of unknown etiology. (clinlabint.com)
  • Charcot-Marie-Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: An international multicentric retrospective study. (cdc.gov)
  • Subtypes are referred to as classic, congenital, transitional, and adult forms of this disease. (uams.edu)
  • The congenital form has similar characteristics but presents early in infancy and features rapid disease progression. (uams.edu)
  • Cerebrotendinous xanthomatosis (CTX) is a rare hereditary autosomal recessive disease caused by the mutations in the CYP27A1 gene, that cause a sterol deficiency of the 27-hydroxylase enzyme involved in the synthesis of bile acids. (amedi.sk)
  • Haplo-insufficiency of PMP22 causes hereditary neuropathy with liability to pressure palsies (HNPP) 4 . (biorxiv.org)
  • The peripheral nervous system sends information from the brain and spinal cord, also called the central nervous system, to the rest of the body through motor nerves. (mayoclinic.org)
  • The peripheral nervous system refers to parts of the nervous system outside the brain and spinal cord. (msdmanuals.com)
  • Commonly known as Lou Gehrig's disease, ALS is a progressive neurodegenerative disease that primarily affects motor neurons in the brain and spinal cord. (gshs.org)
  • Azorean neurologic disease is one of the 40 types of spinocerebellar ataxia (SCA). (brainandnervecenter.com)
  • Neurologic symptoms vary greatly because the nervous system controls many different body functions. (merckmanuals.com)
  • An astrogliopathy and a form of Alexander disease (AxD) characterized by ataxia, bulbar symptoms, spastic paraparesis, palatal myoclonus, and autonomic symptoms. (nih.gov)
  • Autosomal recessive spinocerebellar ataxia 13 (SCAR13) is a neurological disease characterized by psychomotor delay, mild to profound intellectual disability with poor or absent language, nystagmus, stance ataxia, and, if walking is acquired, gait ataxia. (bvsalud.org)
  • Most individuals with PLP1 duplications present with classic Pelizaeus-Merzbacher disease, typified by nystagmus that begins in the first year of life, delayed motor and cognitive milestones, and ataxia. (medscape.com)
  • Diagnostic criteria for HSP included (i) spastic paraparesis or spastic tetraparesis with legs earlier and more severely affected than arms or (ii) spastic paraparesis as early and prominent sign of a neurodegenerative multisystem disease after exclusion of other causes. (biomedcentral.com)
  • To exclude secondary forms of spastic paraparesis standard diagnostic procedures covered MRI of head and spine, vitamin B12 and folic acid levels, very long chain fatty acids (VLCFA), neurometabolic screening (Krabbe disease, metachromatic leukodystrophy, GM1-gangliosidosis, GM2-gangliosidoses Tay Sachs and Sandhoff, Gaucher disease) and cerebrospinal fluid analysis. (biomedcentral.com)
  • The autonomic nervous system regulates physiologic processes. (merckmanuals.com)
  • Oral examination.The oral exam covers all the aspects of the theory of neurological disease. (unicampania.it)
  • Pediatric neurologists treat neurological disease in children. (wikidoc.org)
  • CLASSIFICATION OF DISEASES AND INJURIES I. INFECTIOUS AND PARASITIC DISEASES (001-139) Includes: diseases generally recognized as communicable or transmissible as well as a few diseases of unknown but possibly infectious origin Excludes: acute respiratory infections (460-466) influenza (487. (cdc.gov)
  • It can be the initial demyelinating event in up to 20% of patients, and occurs in almost half of patients with MS.1 ON associated with demyelinating disease is generally characterized by acute to subacute, painful, and monocular vision loss. (clevelandclinic.org)
  • C1-inh is approved for therapy of hereditary angioedema (HAE) and has been studied in a small safety trial in acute NMO relapses (NCT 01759602). (chaen-rcah.ca)
  • Here, we provide an overview of the complement pathways and summarize recent literature related to hereditary and acquired angioedema, infectious diseases, autoimmunity, and age-related macular degeneration. (clinlabint.com)
  • Candidate Genes: Not enough evidence in humans, but potentially associated with the disease. (healthincode.com)
  • Neuromyelitis optica (NMO) is an autoimmune demyelinating disease of the central nervous system in which binding of anti-aquaporin-4 (AQP4) autoantibodies (NMO-IgG) to astrocytes causes complement-dependent cytotoxicity (CDC) and inflammation resulting in oligodendrocyte and neuronal injury. (chaen-rcah.ca)
  • Cerebellar degeneration with Hodgkin disease: an immunological study. (jamanetwork.com)
  • Typically, a predilection exists for distal limbs as the site of disease onset and more severe symptoms and signs. (medscape.com)
  • Moreover, the student must have a deep knowledge of the most common neurological diseases- being able to connect symptoms and signs with diseases. (unicampania.it)
  • They do not indicate the underlying disease process and normal findings do not exclude an organic basis for symptoms. (medscape.com)
  • In addition to a wide range of neurological symptoms, signs of damage of other organ systems can be observed, some of them in childhood. (amedi.sk)
  • other tests may be done to rule out other diseases that may cause similar symptoms. (medicinenet.com)
  • symptoms may reflect deficits in any part of the nervous system. (merckmanuals.com)
  • Vision loss, muscular weakness, muscle spasms, loss of coordination, discomfort, and disturbances in bladder and bowel movement are all frequent symptoms of MS and other demyelinating illnesses. (a2zfitnessmart.com)
  • Ménière disease, recurrent and generally progressive group of symptoms that include loss of hearing, ringing in. (britannica.com)
  • 38 m/s in upper limb motor nerves) in peripheral demyelinating neuropathy such as CMT1 and CMT4. (cmt.org.uk)
  • The immune system mistakenly targets and attacks the motor nerves, resulting in damage and impaired functioning. (gshs.org)
  • This condition occurs when the immune system mistakenly attacks multiple motor nerves. (gshs.org)
  • Hereditary spastic paraplegias (HSPs) are characterised by lower limb spasticity due to degeneration of the corticospinal tract. (biomedcentral.com)
  • AIDS-like syndrome: AIDS-like disease (illness) (syndrome) ARC AIDS-related complex Pre-AIDS AIDS-related conditions Prodromal-AIDS 3. (cdc.gov)
  • The Importance of Multiple Gene Analysis for Diagnosis and Differential Diagnosis in Charcot Marie Tooth Disease. (cdc.gov)
  • Also, some cancers related to the body's immune system can cause polyneuropathy. (mayoclinic.org)
  • In this section, we will discuss some of the most common forms of motor neuropathy, including amyotrophic lateral sclerosis (ALS) , multifocal motor neuropathy (MMN) , primary lateral sclerosis, spinal muscular atrophy, and Kennedy's disease. (gshs.org)
  • Seropositive Devic's disease, according to the diagnostic criteria described above. (mdwiki.org)
  • certain localized infections Note: Categories for "late effects" of infectious and parasitic diseases are to be found at 137. (cdc.gov)
  • myxomatosis, a highly fatal infectious viral disease of rabbits. (britannica.com)
  • In TT disease, thickening is usually confined to 1 nerve. (medscape.com)
  • Now a large and ever increasing number of genetic subtypes has been described, and major advances in molecular and cellular biology have clarified the understanding of the role of different proteins in the physiology of peripheral nerve conduction in health and in disease. (medscape.com)
  • Every nerve in the peripheral system has a specific job. (mayoclinic.org)
  • A hereditary CNS demyelinating disease is a demyelinating central nervous system disease that is primarily due to an inherited genetic condition. (wikipedia.org)
  • Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. (annaly-nevrologii.com)
  • Charcot-Marie-Tooth disease subtypes and genetic testing strategies. (annaly-nevrologii.com)
  • Idiopathic basal ganglia calcification is a hereditary, genetic condition marked by abnormal calcium deposits in parts of the brain that regulate movement. (brainandnervecenter.com)
  • In certain circumstances, you may note disease-causing genetic changes. (a2zfitnessmart.com)
  • There are approximately 5,000 to 8,000 distinct uncommon diseases, most of which have a genetic basis. (a2zfitnessmart.com)
  • Charcot-Marie-Tooth disease: Genetic profile of patients from a large Brazilian neuromuscular reference center. (cdc.gov)
  • Families with confirmed Pelizaeus-Merzbacher disease must be referred to a geneticist or neurogeneticist for education about the disease and, especially, for genetic counseling. (medscape.com)
  • Opthalmoneuromyelitis, also known as Devic disease, is an acquired condition triggered by autoimmune reactions and certain microbial infections. (brainandnervecenter.com)
  • Clinically, patients typically describe central (less commonly arcuate, cecocentral, or hemianopic) vision loss that progresses over hours to days. (clevelandclinic.org)